Ratio Therapeutics Closes $70M Series C Financing
Round brings total capital raised to over $240M.
Posted in BioUtah News
Tagged Ratio Therapeutics
Comments Off on Ratio Therapeutics Closes $70M Series C Financing
Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs
Collaboration strengthens Ratio’s long-term isotope supply strategy for clinical development and future pipeline growth.
Posted in BioUtah News
Tagged Ratio Therapeutics
Comments Off on Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs
